Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Prostate Cancer
N/A
N/A
Male
Prostatic Neoplasms
Trial Information
Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Prostate Cancer
Our initial assessment indicates that electromagnetic radiation of the central nervous
system, the viscera and the endocrine system has the potential to cure a number of diseases,
including prostate cancer.
Inclusion Criteria:
- Persons with Prostate, Bladder or Testicular Cancer.
Exclusion Criteria:
- None
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
The primary end point is to determine the therapeutic effects of far infrared radiation on Prostate Cancer.
Outcome Time Frame:
2 years and 6 months
Safety Issue:
No
Principal Investigator
Ken Nedd, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
GAAD Medical Research Institute Inc.
Authority:
Canada: Health Canada
Study ID:
GAAD-PC-CTP1
NCT ID:
NCT00573820
Start Date:
January 2006
Completion Date:
December 2008
Related Keywords:
- Prostatic Neoplasms
- Tumors or cancer of the prostate
- Cancer of Prostate
- Cancer of the Prostate
- Neoplasms, Prostate
- Neoplasms, Prostatic
- Prostate Cancer
- Prostate Neoplasms
- Prostatic Cancer
- Neoplasms
- Prostatic Neoplasms
Name | Location |
|---|
